LFWD – lifeward ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
FDA Issues Clearance for ReWalk 7 Exoskeleton
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its price target lowered by analysts at Lake Street Capital from $4.50 to $4.00. They now have a "buy" rating on the stock.
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
Form 8-K Lifeward Ltd. For: Mar 07
Form 424B5 Lifeward Ltd.
Form 10-K Lifeward Ltd. For: Dec 31
Form 8-K Lifeward Ltd. For: Mar 07
Form 8-K Lifeward Ltd. For: Feb 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.